Novus Diagnostics
PrivateLast Round
Series A
Oct 25, 2024
Est. Valuation
$20M
Total Funding Raised
$14M
Company Overview
Novus Diagnostics is a medical device company that develops rapid point-of-care diagnostic solutions for the detection and classification of infectious diseases, specifically sepsis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novus Diagnostics Comparables
Compare Novus Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deepull | 87% | |
| Abionic SA | 86% | |
| Eroica Dx | 83% |
Novus Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 25, 2024 | ||||
| VC Round | Nov 21, 2022 | ||||
| Grant | Jan 12, 2021 |
Key People
Founding team and executive leadership
Novus Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Venture Partners | Series A |
| Irrus Investments | Series A |
| European Innovation Council Fund | VC Round, Grant |
| Enterprise Ireland | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 25, 2024
$5M round led by Business Venture Partners, Irrus Investments, and Trinity Biotech plc.
- Apr 9, 2024
Grew 23% QoQ, from 13 to 16 employees.
Novus Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access